• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Philips, HEARTSTART, INFANT/CHILD SMART PADS CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Philips, HEARTSTART, INFANT/CHILD SMART PADS CARTRIDGE see related information
Date Initiated by Firm July 16, 2021
Date Posted September 03, 2021
Recall Status1 Terminated 3 on May 12, 2023
Recall Number Z-2427-2021
Recall Event ID 88361
PMA Number P160029 
Product Classification Pads for Automated external defibrillators (non-wearable) - Product Code MKJ
Product Philips, HEARTSTART, INFANT/CHILD - SMART PADS CARTRIDGE, REF: M5072A, (0-8 YEARS)< 55 lbs / 25 kg, CE 0123, NON-STERILE, Rx only, UDI: (01) 00884838023758 for use with defibrillator
Code Information Lot Y111220-01
Recalling Firm/
Manufacturer
Philips North America LLC
22100 Bothell Everett Hwy
Bothell WA 98021-8431
For Additional Information Contact Philips Customer Services
1800-722-9377
Manufacturer Reason
for Recall
Infant/Child defibrillator pads contain incorrect labeling. This could lead to a delay in therapy, or delivery of lower energy than indicated for an adult patient
FDA Determined
Cause 2
Process control
Action On July 26, 2021, Phillips issued an "Urgent Medical Device Removal" notification to affected consignees. On August 23, 2021, Phillips issued a revised "Urgent Medical Device Removal notification to update their recall strategy concerning replacement infant/child smart pads cartridges. In addition to informing consignees about the recalled product, Phillips asked consignees to take the following actions: Action 1: If needed, contact your distributor to request a replacement. Customers who purchased their pads cartridges directly from Philips will receive their replacements without any further action on their part. Customers who purchases their pads cartridges from a distributor should contact that distributor to request replacement. Replacement pads cartridges may not be available immediately, therefore, refer to Action 2, below. Action 2: Determine if the Infant/Child SMART Pads may remain in service until replaced. 1. Philips, or your Philips Distributor, will supply a replacement of all M5072A Infant/Child SMART Pads Cartridges from Lot Number Y111220-01. 2. If the Infant/Child SMART Pads Cartridge is still inside the pouch, then it can remain in service until replaced. While waiting to receive the replacement, customers should keep the Infant/Child SMART Pads Cartridge inside the outer pouch until the cartridge is replaced, or until it is needed for therapy. The reason is because the pouch correctly identifies the cartridge as intended for infant/child patients. (Figure 7). 3. If the Infant/Child SMART Pads Cartridge has been removed from the outer pouch, and if the protective cover shows a drawing of pads placement for a child s chest and back, then it can remain in service until replaced. The reason is because the protective cover has the correct image with the image of a child s chest and back. (Figure 8). 4. If the Infant/Child SMART Pads Cartridge has been removed from the outer pouch, and if the protective cover shows a dra
Quantity in Commerce 19,840 units
Distribution Worldwide distribution. US Nationwide, Australia, Austria, Bolivia, Canada, Chile, China, Denmark, France, French Polynesia, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Republic of Korea, Malta, Martinique, Mexico, Monaco, Netherlands, Norway, Poland, Spain, Switzerland, Taiwan, United Kingdom, and Uruguay
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-